A cross-sectional study of risk factors associated with sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease
Johnny Amer, Qusay Abdoh, Zaina Salous, Eithar Abu Alsoud et autres
Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic liver disease linked to several adverse health consequences that include metabolic disturbances affecting skeletal muscle. Sarcopenia, characterized by skeletal muscle loss, is commonly observed in individuals with MASLD. Our study aimed to …
ps, sg (code pays fourni par la source)
7 citations
Frontiers in Medicine